We are also extending our research from genome to epigenome, e.g., we are performing epigenome-wide profiling of osteoporosis at micro-RNA, DNA phosphorylation and histone modification levels. In particular, we are interested in developing novel statistical methods and bioinformatics tools for analyzing and managing large, complex datasets in genomic and epigenomic research.
Through Louisiana Osteoporosis Study (LOS), we are building a large research cohort and database for human complex disease studies. The LOS will enroll >20,000 subjects of different ethnicities inNew Orleans , Baton Rouge and their surrounding areas. Each subject will be phenotyped for body composition (including bone mineral density, lean and fat mass), muscle function, and blood pressure etc., and assayed for important health-related and life-style information. Their blood samples will be collected for extraction of DNA, RNA and proteins and for cell isolation and biobanking. The LOS will become a sample pool for selecting subjects of extreme phenotypes (e.g., extremely high vs. low bone mass) for our ongoing funded and future genomic and epigenomic studies.
- Hong-Wen Deng, Ph.D., PI
- Jun Chen: Postdoc Fellow
- Yingchun Zhao: Postdoc Fellow
- Shufeng Lei: Postdoc Fellow
- Chao Xu: Research Assistant
- NIH 1R01AR057049-01A1, Hong-Wen Deng (PI) 9/1/09-8/30/14Title: Identification of proteins important for male osteoporosisTo perform proteomics experiments to identify genes in monocytes and bone marrow mesenchymal stem cells important for male osteoporosis.
- NIH 2R01AR050496-06A1, Hong-Wen Deng (PI) 9/01/09-8/30/14Title: Robust and powerful test of candidate genes to bone massSystematically test for association of ten candidate genes for bone mass variation.
- NIH R01AG026564, Hong-Wen Deng (PI) 3/1/07-2/28/11Title: Genomic search for bone mass QTLsTo perform whole genome linkage studies and fine mapping in large pedigrees for bone mass QTLs.
- NIH 1P50AR055081-01, Hong-Wen Deng (Program PI) 9/1/07-8/30/12Title: Genomic Convergence for Female Osteoporosis Risk GenesTo perform a comprehensive study using approaches of genome wide association search for DNA polymorphisms,, RNA and proteins to identify genes and their functions important for female bone mass variation
- NIH 1 RC2 DE20756-01, Hong-Wen Deng (Multiple PI) 10/1/09-09/30/10Title: Genome-wide association study of periodontitisTo perform a pilot study for a large-scale genome-wide association study of periodontitis.
- NIH 1R03TW008221-01A1, Hong-Wen Deng (PI) 9/1/09-06/30/12Title: Genetics of Osteoporotic Fractures in ChineseTo perform a candidate gene-based association study for osteoporotic fractures in Chinese
Whole genome sequencing studies are essential to obtain a comprehensive understanding of the vast pattern of human genomic variations. Here we report the results of a high-coverage whole genome sequencing study for 44 unrelated healthy Caucasian adults, each sequenced to over 50-fold coverage (averaging 65.8x). We identified approximately 11 million single nucleotide polymorphisms (SNPs), 2.8 million short insertions and deletions, and over 500,000 block substitutions. We showed that, although previous studies, including the 1000 Genomes Project Phase 1 study, have catalogued the vast majority of common SNPs, many of the low-frequency and rare variants remain undiscovered. For instance, approximately 1.4 million SNPs and 1.3 million short indels were novel to both the dbSNP and the 1000 Genomes Project Phase 1 data sets. On average, each individual genome carried approximately 330 loss-of-function variants that resulted in protein truncation, frameshift change, or the loss of a stop codon. At the population level, an average of 103 of these variants occurred in a homozygous state in an individual genome, which would completely "knock out" the annotated genes. Interestingly, while majority of these genes were "knocked-out" in just one or two individual genomes, a number of genes that are mainly related to antigen processing and immune response were frequently "knocked-out" in general populations. Our results contribute towards a comprehensive characterization of human genomic variation, especially for less-common and rare variants, and provide an invaluable resource for future genetic studies of human variation and diseases.